Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.

N Brooks, J Wright, M Sturridge, J Pepper, P Magee, R Walesby, C Layton, M Honey, R Balcon

Treatment with the combination of aspirin and dipyridamole is believed to reduce the incidence of coronary vein graft occlusion. A double blind randomised controlled trial was carried out in which aspirin 990 mg and dipyridamole 225 mg daily or placebo were added to the routine postoperative management (warfarin for three months) of 320 patients undergoing coronary bypass grafting. The trial treatment was given for 12 months, after which the results were assessed by coronary and graft angiography. The two randomised groups, each of 160 patients, were comparable in age, sex, symptomatic state, angiographic findings, and operative procedure. Repeat coronary arteriography was carried out on 266 patients, 133 in each group. All grafts and distal anastomoses were patent in 68% (91/133) of the placebo patients and in 75% (100/133) of those receiving active treatment. Overall graft patency was 87% (306/352) and 89% (342/385) respectively. Retrospective subgroup analysis showed patency rates of 72% (26/36) and 78% (39/50) of grafts to vessels requiring preliminary endarterectomy, and 80% (36/45) and 91% (40/44) of distal anastomoses to vessels measured at operation to have a diameter of less than or equal to 1 mm. None of these differences was significant at the 5% level. Thus in this group of patients with high graft patency rates, treatment with aspirin and dipyridamole conferred no appreciable advantage.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Becker, R. C., Meade, T. W., Berger, P. B., Ezekowitz, M., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H., Mark, D. B., Harrington, R. A. (2008). The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 776S-814S [Abstract] [Full Text]  
• Epstein, A. E., Alexander, J. C., Gutterman, D. D., Maisel, W., Wharton, J. M. (2005). Anticoagulation: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery. Chest 128: 24S-27S [Abstract] [Full Text]  
• Okrainec, K., Platt, R., Pilote, L., Eisenberg, M. J. (2005). Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trials. J Am Coll Cardiol 45: 177-184 [Abstract] [Full Text]  
• Stein, P. D., Schunemann, H. J., Dalen, J. E., Gutterman, D. (2004). Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 600S-608S [Abstract] [Full Text]  
• Lim, E., Ali, Z., Ali, A., Routledge, T., Edmonds, L., Altman, D. G, Large, S. (2003). Indirect comparison meta-analysis of aspirin therapy after coronary surgery. BMJ 327: 1309- [Abstract] [Full Text]  
• Foody, J. M., Ferdinand, F. D., Galusha, D., Rathore, S. S., Masoudi, F. A., Havranek, E. P., Nilasena, D., Radford, M. J., Krumholz, H. M. (2003). Patterns of Secondary Prevention in Older Patients Undergoing Coronary Artery Bypass Grafting During Hospitalization for Acute Myocardial Infarction. Circulation 108: II-24-28 [Abstract] [Full Text]  
• Stein, P. D., Dalen, J. E., Goldman, S., Theroux, P. (2001). Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts. Chest 119 : 278S-282S [Full Text]  
• Liau, C.-S., Chen, M.-F., Lee, C.-M., Chen, W.-J., Wu, C.-C., Chu, S.-H., Lee, Y.-T. (1995). Effects of Increased Pressure and Oxygen on the Growth Rate of Cultured Endothelial Cells Derived from Human Saphenous Vein. VASC ENDOVASCULAR SURG 29: 43-48 [Abstract]  
• (1994). Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 308: 159-168 [Abstract] [Full Text]  
• Antiplatelet Trialists, (1994). Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308: 81-106 [Abstract] [Full Text]  
• Wong, J. B., Sonnenberg, F. A., Salem, D. N., Pauker, S. G. (1990). Myocardial Revascularization for Chronic Stable Angina: Analysis of the Role of Percutaneous Transluminal Coronary Angioplasty Based on Data Available in 1989. ANN INTERN MED 113: 852-871 [Abstract]  
• Clagett, G. P. (1990). Antithrombotic Drugs and Vascular Surgery. PERSPECT VASC SURG ENDOVASC THER 3: 79-102  
• Henderson, W. G., Goldman, S., Copeland, J. G., Moritz, T. E., Harker, L. A. (1989). Antiplatelet or Anticoagulant Therapy after Coronary Artery Bypass Surgery: A Meta-Analysis of Clinical Trials. ANN INTERN MED 111: 743-750 [Abstract]